Literature DB >> 27056152

What Is the Biological and Clinical Relevance of Fibrin?

Rustem I Litvinov1, John W Weisel1.   

Abstract

As our knowledge of the structure and functions of fibrinogen and fibrin has increased tremendously, several key findings have given some people a superficial impression that the biological and clinical significance of these clotting proteins may be less than earlier thought. Most strikingly, studies of fibrinogen knockout mice demonstrated that many of these mice survive to weaning and beyond, suggesting that fibrin(ogen) may not be entirely necessary. Humans with afibrinogenemia also survive. Furthermore, in recent years, the major emphasis in the treatment of arterial thrombosis has been on inhibition of platelets, rather than fibrin. In contrast to the initially apparent conclusions from these results, it has become increasingly clear that fibrin is essential for hemostasis; is a key factor in thrombosis; and plays an important biological role in infection, inflammation, immunology, and wound healing. In addition, fibrinogen replacement therapy has become a preferred, major treatment for severe bleeding in trauma and surgery. Finally, fibrin is a unique biomaterial and is used as a sealant or glue, a matrix for cells, a scaffold for tissue engineering, and a carrier and/or a vector for targeted drug delivery. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27056152      PMCID: PMC5536100          DOI: 10.1055/s-0036-1571342

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  105 in total

Review 1.  Development of platelet contractile force as a research and clinical measure of platelet function.

Authors:  Marcus E Carr
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

Review 2.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

3.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 4.  Fibrinogen replacement therapy for congenital fibrinogen deficiency.

Authors:  L Bornikova; F Peyvandi; G Allen; J Bernstein; M J Manco-Johnson
Journal:  J Thromb Haemost       Date:  2011-09       Impact factor: 5.824

5.  Mechanics and contraction dynamics of single platelets and implications for clot stiffening.

Authors:  Wilbur A Lam; Ovijit Chaudhuri; Ailey Crow; Kevin D Webster; Tai-De Li; Ashley Kita; James Huang; Daniel A Fletcher
Journal:  Nat Mater       Date:  2010-12-05       Impact factor: 43.841

6.  Role of EVICEL Fibrin Sealant to Assist Hemostasis in Cranial and Spinal Epidural Space: A Neurosurgical Clinical Study.

Authors:  Roberto Gazzeri; Claudio Fiore; Marcelo Galarza
Journal:  Surg Technol Int       Date:  2015-05

Review 7.  A short contemporary history of disseminated intravascular coagulation.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Semin Thromb Hemost       Date:  2014-11-06       Impact factor: 4.180

8.  The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.

Authors:  Petra Innerhofer; Isabella Westermann; Helmuth Tauber; Robert Breitkopf; Dietmar Fries; Tobias Kastenberger; Rene El Attal; Alexander Strasak; Markus Mittermayr
Journal:  Injury       Date:  2012-09-20       Impact factor: 2.586

Review 9.  The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.

Authors:  Dietmar Fries
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

10.  Malpighi's De polypo cordis: an annotated translation.

Authors:  J M Forrester
Journal:  Med Hist       Date:  1995-10       Impact factor: 1.419

View more
  26 in total

1.  Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.

Authors:  Lauren R Schmitt; Rachel Henderson; Alexander Barrett; Zsuzsanna Darula; Aaron Issaian; Angelo D'Alessandro; Nathan Clendenen; Kirk C Hansen
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

2.  Proteomic biomarkers of sleep apnea.

Authors:  Aditya Ambati; Yo-El Ju; Ling Lin; Alexander N Olesen; Henriette Koch; Julien Jacques Hedou; Eileen B Leary; Vicente Peris Sempere; Emmanuel Mignot; Shahrad Taheri
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

3.  Contribution of nascent cohesive fiber-fiber interactions to the non-linear elasticity of fibrin networks under tensile load.

Authors:  Samuel Britton; Oleg Kim; Francesco Pancaldi; Zhiliang Xu; Rustem I Litvinov; John W Weisel; Mark Alber
Journal:  Acta Biomater       Date:  2019-05-30       Impact factor: 8.947

4.  Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability.

Authors:  Rami Abu-Fanne; Victoria Stepanova; Rustem I Litvinov; Suhair Abdeen; Khalil Bdeir; Mohamed Higazi; Emad Maraga; Chandrasekaran Nagaswami; Alexander R Mukhitov; John W Weisel; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

Review 5.  Red blood cells: the forgotten player in hemostasis and thrombosis.

Authors:  J W Weisel; R I Litvinov
Journal:  J Thromb Haemost       Date:  2019-01-07       Impact factor: 5.824

6.  Autologous fibroblasts, peripheral blood mononuclear cells, and fibrin glue accelerate healing of refractory cutaneous ulcers in diabetic mice.

Authors:  Takahiro Mizoguchi; Koji Ueno; Masashi Yanagihara; Makoto Samura; Hiroshi Kurazumi; Ryo Suzuki; Noriyasu Morikage; Kimikazu Hamano
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

Review 7.  3D Bioprinting for Organ Regeneration.

Authors:  Haitao Cui; Margaret Nowicki; John P Fisher; Lijie Grace Zhang
Journal:  Adv Healthc Mater       Date:  2016-12-20       Impact factor: 9.933

8.  Nattokinase-heparin exhibits beneficial efficacy and safety-an optimal strategy for CKD patients on hemodialysis.

Authors:  Hao Wu; Huan Wang; Wei Li; Chi Zhang; Yushan Liu; Feng Xu; Jiepeng Chen; Lili Duan; Fengjiao Zhang
Journal:  Glycoconj J       Date:  2019-02-20       Impact factor: 2.916

9.  Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).

Authors:  Kelly Njine Mouapi; Lucille J Wagner; Chad A Stephens; Mohammed M Hindi; Daniel W Wilkey; Michael L Merchant; Muriel C Maurer
Journal:  Thromb Haemost       Date:  2019-05-05       Impact factor: 5.249

Review 10.  Blood will out: vascular contributions to Alzheimer's disease.

Authors:  Sidney Strickland
Journal:  J Clin Invest       Date:  2018-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.